Literature DB >> 3917277

MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.

G B Thurman, I A Braude, P W Gray, R K Oldham, H C Stevenson.   

Abstract

By utilizing elutriation-purified human monocytes, we found that human interferon (IFN) inhibits monocyte migration in a manner similar to migration inhibitory factor (MIF) and does it without demonstrable cytotoxicity. We observed that human IFN-gamma is 10 to 300 times more potent in its MIF activity than is IFN-alpha and that monoclonal antibodies (MoAb) can be used to distinguish between them. Studies with recombinant IFN-gamma indicate that the migration inhibition seen with natural IFN-gamma is due to IFN-gamma itself and is not due to co-purification of another lymphokine with the natural IFN-gamma. Although interferons exhibit MIF activities, there are apparently other cytokines, without antiviral activity, that also have MIF activities. MIF from the lymphoblastoid cell line RPMI 1788 was not neutralized by MoAb to IFN. However, MIF activity in supernatant fluid from human peripheral blood lymphocyte cultures stimulated with Con A-Sepharose was completely neutralized with MoAb anti-IFN-gamma. These data indicate that MIF is really a family of cytokines that inhibit macrophage/monocyte migration and that the major portion of MIF activity associated with crude supernatant of mitogen-stimulated lymphocytes is due to IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917277

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

2.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factor.

Authors:  I M Orme; S K Furney; P S Skinner; A D Roberts; P J Brennan; D G Russell; H Shiratsuchi; J J Ellner; W Y Weiser
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

4.  Differential effect of alpha-interferon and gamma-interferon on thromboplastin response in monocytes and endothelial cells.

Authors:  E Carlsen; M B Stinessen; H Prydz
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 5.  Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis.

Authors:  H Widner; P Brundin
Journal:  Brain Res       Date:  1988-11       Impact factor: 3.252

6.  Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum.

Authors:  J F DeLamarter; J J Mermod; C M Liang; J F Eliason; D R Thatcher
Journal:  EMBO J       Date:  1985-10       Impact factor: 11.598

7.  An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.

Authors:  J Bernhagen; M Bacher; T Calandra; C N Metz; S B Doty; T Donnelly; R Bucala
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

8.  Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

Authors:  F Herrmann; S A Cannistra; H Levine; J D Griffin
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

9.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

10.  Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.

Authors:  A McInnes; D M Rennick
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.